Beurs gesloten -
OTC Markets
18:28:55 05-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
0,0001
USD
|
0,00%
|
|
0,00%
|
-93,33%
|
Fiscaal tijdperk: September |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
5,384
|
0,1723
|
0,4404
|
256,2
|
21,53
|
5,536
|
Bedrijfswaarde
1 |
7,672
|
4,001
|
-0,9578
|
256,4
|
25,51
|
24,3
|
K/w-verhouding
|
-6,57
x
|
-0,02
x
|
-5,15
x
|
-40,5
x
|
-1,59
x
|
-0,18
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
-
|
-
|
2.430.031
x
|
506.736.960
x
|
37.911.709
x
|
9.123.905
x
|
Bedrijfswaarde/omzet
|
-
|
-
|
-5.285.054
x
|
507.041.226
x
|
44.915.754
x
|
40.045.900
x
|
Bedrijfswaarde/EBITDA
|
-4,32
x
|
-2,27
x
|
0,29
x
|
-47,6
x
|
-2,23
x
|
-2,85
x
|
Bedrijfswaarde/FCF
|
-0,88
x
|
0,64
x
|
0,34
x
|
-173
x
|
-11,8
x
|
1,23
x
|
FCF Yield
|
-114%
|
156%
|
291%
|
-0,58%
|
-8,48%
|
81,1%
|
Price to Book
|
-0,77
x
|
-0,02
x
|
-5.250
x
|
-51,8
x
|
-3,17
x
|
-0,15
x
|
Aantal aandelen (in duizenden)
|
326
|
467
|
1.398
|
5.124.165
|
6.151.500
|
6.151.500
|
Referentieprijs
2 |
16,50
|
0,3688
|
0,3150
|
0,0500
|
0,003500
|
0,000900
|
Datum van publicatie
|
1/04/19
|
25/03/20
|
27/09/21
|
13/01/22
|
29/12/22
|
5/01/24
|
Fiscaal tijdperk: September |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
|
-
|
-
|
0,1812
|
0,5056
|
0,5679
|
0,6068
|
EBITDA
1 |
-1,776
|
-1,766
|
-3,259
|
-5,38
|
-11,45
|
-8,532
|
Bedrijfsresultaat (EBIT)
1 |
-1,778
|
-1,769
|
-3,357
|
-5,566
|
-11,64
|
-8,741
|
Operationele Marge
|
-
|
-
|
-1.852,24%
|
-1.100,86%
|
-2.049,64%
|
-1.440,47%
|
Resultaat voor belastingen (EBT)
1 |
6,468
|
-9,402
|
-3,17
|
-5,472
|
-12,74
|
-30,91
|
Nettowinst (verlies)
1 |
6,468
|
-9,402
|
-3,17
|
-5,472
|
-12,74
|
-30,91
|
Nettomarge
|
-
|
-
|
-1.749,32%
|
-1.082,2%
|
-2.243,68%
|
-5.093,56%
|
WPA
2 |
-2,510
|
-19,00
|
-0,0611
|
-0,001236
|
-0,002207
|
-0,005030
|
Free Cash Flow
1 |
-8,714
|
6,256
|
-2,788
|
-1,482
|
-2,162
|
19,71
|
FCF-marge
|
-
|
-
|
-1.538,27%
|
-293,12%
|
-380,67%
|
3.248,94%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
1/04/19
|
25/03/20
|
27/09/21
|
13/01/22
|
29/12/22
|
5/01/24
|
Fiscaal tijdperk: September |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
2,29
|
3,83
|
-
|
0,15
|
3,98
|
18,8
|
Nettokaspositie
1 |
-
|
-
|
1,4
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-1,289
x
|
-2,168
x
|
-
|
-0,0286
x
|
-0,3474
x
|
-2,199
x
|
Free Cash Flow
1 |
-8,71
|
6,26
|
-2,79
|
-1,48
|
-2,16
|
19,7
|
ROE (netto-inkomsten/eigen vermogen)
|
-57,9%
|
80,1%
|
-598%
|
4.326%
|
443%
|
147%
|
ROA (netto-inkomsten/totale activa)
|
-876%
|
-689%
|
-97,6%
|
-144%
|
-343%
|
-201%
|
Totale activa
1 |
-0,7385
|
1,364
|
3,248
|
3,802
|
3,711
|
15,41
|
Nettoactief per aandeel
2 |
-21,40
|
-18,60
|
-0
|
-0
|
-0
|
-0,0100
|
Cashflow per aandeel
2 |
0
|
0,0300
|
0
|
0
|
0
|
0
|
Capex
|
-
|
0,04
|
0,53
|
0,14
|
0,13
|
0,16
|
Capex/omzet
|
-
|
-
|
293,3%
|
26,84%
|
23,17%
|
26,93%
|
Datum van publicatie
|
1/04/19
|
27/09/21
|
27/09/21
|
13/01/22
|
29/12/22
|
5/01/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -93,33% | 615K | | +18,72% | 125 mld. | | +14,19% | 108 mld. | | -4,93% | 24,21 mld. | | +3,23% | 22,78 mld. | | -10,44% | 17,96 mld. | | -41,74% | 16,43 mld. | | -13,31% | 16,37 mld. | | +2,44% | 13,58 mld. | | +27,89% | 11,66 mld. |
Biotherapeutische geneesmiddelen
|